Indietro

Bruker Corporation

Ticker: BRKR ISIN: US1167941087
Aggiungi al portafoglio Analisi del portafoglio in 2min
Stock Mid-cap Dividend payer Trading above 200-day average
Capitalizzazione
8,00 Mld $
Forward P/E
23,75
Profit margin
-0,61%
Revenue growth QoQ
-0,50%
Div. yield
0,39%
Beta
1,17
56,98 $ -4,33%
Prezzo al 2026-08-24 · NASDAQ

Performance per periodo

Rendimenti cumulativi
1 Month -5,11%
6 Months +43,62%
1 Year +65,45%
5 Years -7,93% p.a.-33,83%
10 Years +10,13% p.a.+162,18%
Since inception +5,27% p.a.+260,50%
Rendimenti per anno
YTD +21,24%
2025 -19,23%
2024 -19,99%
2023 +7,82%
2022 -18,29%
2021 +55,35%

Key stats

Market cap
8,00 Mld
Dividend yield
0,39%
Beta
1,17
52-week range
28.46 - 64.32
50-day MA
44,41
200-day MA
39,13
Section 1

Business overview

Company profile data from fundamentals.

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper platform for bacterial and fungal identification and establish, DNA test strips, and; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was founded in 1960 and is headquartered in Billerica, Massachusetts.

Sector Healthcare
Industry Medical Devices
Country United States
Exchange NASDAQ
Section 2

Financial quality

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE -1,09%
ROA 3,68%
Profit margin -0,61%
Operating margin 12,96%
PEG ratio 3,64
Revenue/share TTM 22,67
Revenue TTM 3,44 Mld
EBITDA 585,00 Mln
Gross profit TTM 1,68 Mld
Beta 1,17

Valuation

Trailing P/E 0,00
Forward P/E 23,75
P/B 3,29
P/S 2,33
EV/EBITDA 33,55
EV/Revenue 2,83
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) 1,88
Quarterly earnings growth 0,00%
Revenue TTM 3,44 Mld
Reported quarters 102
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Dividend yield 0,39%
Forward annual div. yield 0,38%
Dividend per share 0,2000
Payout ratio 11,56%
Ex-dividend date 2025-12-08
Last split date 0000-00-00
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Analyst

Analyst target price 52,36 $
Analyst rating 3.8571

Ownership & short interest

Shares outstanding 151,94 Mln
Shares float 103,31 Mln
Institutional ownership 90,20%
Insider ownership 31,94%
Short ratio 4,88
Short % of float 16,29%

Details

Instrument metadata and source update timestamps.

Symbol BRKR
Name Bruker Corporation
Asset type STOCK
Exchange NASDAQ
Currency USD
ISIN US1167941087
Country USA
Code + exchange BRKR.NASDAQ
Last price date 2026-01-06
Fundamentals updated 2026-01-07

Le informazioni fornite su questa piattaforma hanno solo scopo informativo e non devono essere considerate consulenza finanziaria o di investimento. Insightfolio non fornisce consulenza d'investimento, raccomandazioni personalizzate o indicazioni relative all'acquisto, alla detenzione o alla vendita di strumenti finanziari. Gli strumenti e i contenuti sono destinati esclusivamente a finalita educative e non sono adattati alle circostanze individuali, alle esigenze finanziarie o agli obiettivi personali.

Insightfolio non si assume alcuna responsabilita per l'accuratezza, la completezza o l'affidabilita delle informazioni presentate. Gli utenti sono gli unici responsabili della verifica delle informazioni e dell'assunzione di decisioni indipendenti basate sulla propria ricerca e su un'attenta valutazione. L'uso della piattaforma non deve sostituire la consulenza di professionisti finanziari qualificati.

Gli investimenti comportano rischi. Gli utenti devono essere consapevoli che il valore degli investimenti puo variare e che i rendimenti passati non sono indicativi di risultati futuri. Le decisioni di investimento devono basarsi sugli obiettivi finanziari personali, sulla tolleranza al rischio e su una valutazione indipendente delle informazioni rilevanti.

Insightfolio non approva ne garantisce l'idoneita di alcun prodotto finanziario, titolo o strategia specifica. Eventuali proiezioni, previsioni o scenari ipotetici presentati sulla piattaforma hanno solo scopo illustrativo e non costituiscono garanzia di risultati futuri.

Accedendo ai servizi, alle informazioni o ai contenuti offerti da Insightfolio, gli utenti riconoscono e accettano i presenti termini di esclusione di responsabilita. Se non accetti questi termini, ti invitiamo a non utilizzare la piattaforma.

Instrument logos provided by Elbstream.